The Business Times

Novo Nordisk

International

Novo Nordisk lowers full-year profit guidance in new CEO’s maiden quarter

The tussle for Metsera began with discussions between the company and potential acquirers in early 2024, with both Pfizer and Novo Nordisk, the maker of Wegovy and Ozempic, expressing interest.
Companies & Markets

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

Novo Nordisk has gone from being Europe’s most valuable listed company to losing more than US$300 billion in market value.
Opinion & Features
THINKING ALOUD

How I knew when to start backing Novo Nordisk’s biggest rival instead

(FILES) An employee walks past a door bearing the logo of Novo Nordisk at the factory in Hilleroed on September 26, 2023. Danish pharmaceutical firm Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, announced on August 6, 2025, a 32 percent increase in net profit for the second quarter. (Photo by Sergei GAPON / AFP)
Global Enterprise

Ozempic-maker Novo Nordisk to cut 9,000 jobs in restructuring

FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo
Companies & Markets

Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle

FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo
Companies & Markets

Novo Nordisk overtakes SAP as Europe’s most valuable company

FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo
Companies & Markets

Novo Nordisk latest drugmaker to drop gender goals in US

FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo
Companies & Markets

All assets of biotech founder in Novo Nordisk suit frozen, including US$218 million in DBS account

FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo
Companies & Markets

Novo Nordisk launches obesity drug Wegovy in China

FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo
International

Novo Nordisk is gradually phasing out human insulin pens globally

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More